Cargando…

Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications

DCLK1 specifically marks colon/pancreatic cancers in mice, and is expressed by human colon adenocarcinomas (hCRCs). Down-regulation of DCLK1 results in loss of cancer-stem-cells (CSCs), and inhibits spheroidal/xenograft growths from hCRC-cells. The 5′-promoter of DCLK1-gene is reportedly hypermethyl...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Connell, Malaney R., Sarkar, Shubhashish, Luthra, Gurinder K., Okugawa, Yoshinaga, Toiyama, Yuji, Gajjar, Aakash H., Qiu, Suimin, Goel, Ajay, Singh, Pomila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597220/ https://www.ncbi.nlm.nih.gov/pubmed/26447334 http://dx.doi.org/10.1038/srep14983

Ejemplares similares

Methods for Detecting Circulating Cancer Stem Cells (CCSCs) as a Novel Approach for Diagnosis of Colon Cancer Relapse/Metastasis
por: Kantara, Carla, et al.
Publicado: (2014)

A novel antibody against cancer-stem-cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy
por: Sarkar, Shubhashish, et al.
Publicado: (2017)

A metastasis‐associated microRNA‐based liquid biopsy signature for risk‐stratification in colorectal cancer: a multicenter cohort study
por: Matsuyama, Takatoshi, et al.
Publicado: (2022)

Mechanistic and evolutionary insights into isoform-specific ‘supercharging’ in DCLK family kinases
por: Venkat, Aarya, et al.
Publicado: (2023)

Mechanistic and evolutionary insights into isoform-specific ‘supercharging’ in DCLK family kinases
por: Venkat, Aarya, et al.
Publicado: (2023)

DCLK1 isoforms and aberrant Notch signaling in the regulation of human and murine colitis
por: Roy, Badal C., et al.
Publicado: (2021)

Correction: DCLK1 isoforms and aberrant Notch signaling in the regulation of human and murine colitis
por: Roy, Badal C., et al.
Publicado: (2021)

The role of miR-21 as a predictive biomarker and a potential target to improve the effects of chemoradiotherapy against head and neck squamous cell carcinoma
por: Ishinaga, Hajime, et al.
Publicado: (2023)

Oncogenic functions and clinical significances of DCLK1 isoforms in colorectal cancer: a systematic review and meta-analysis
por: Kalantari, Elham, et al.
Publicado: (2022)

DCLK1 immunoreactivity in colorectal neoplasia
por: Gagliardi, Giuseppe, et al.
Publicado: (2012)

DCLK1 autoinhibition and activation in tumorigenesis
por: Cheng, Linna, et al.
Publicado: (2021)

Analysis of the clinical significance of DCLK1(+) colorectal cancer using novel monoclonal antibodies against DCLK1
por: Dai, Tianqi, et al.
Publicado: (2018)

The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer
por: Vedeld, Hege Marie, et al.
Publicado: (2014)

Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer
por: Okugawa, Yoshinaga, et al.
Publicado: (2018)

Late-onset peritoneal recurrence of advanced gastric cancer 20 years after primary resection
por: Okugawa, Yoshinaga, et al.
Publicado: (2010)

Double inferior vena cava, an uncommon but relevant anatomical anomaly in surgery for lower rectal cancer: a report of two cases
por: Kawamura, Mikio, et al.
Publicado: (2023)

Structural Basis of Inhibition of DCLK1 by Ruxolitinib
por: Jang, Dong Man, et al.
Publicado: (2021)

Brain-Derived Neurotrophic Factor (BDNF)-Induced Tropomyosin-Related Kinase B (Trk B) Signaling Is a Potential Therapeutic Target for Peritoneal Carcinomatosis Arising from Colorectal Cancer
por: Tanaka, Koji, et al.
Publicado: (2014)

Exacerbation of Dermatomyositis with Recurrence of Rectal Cancer: A Case Report
por: Nagano, Yuka, et al.
Publicado: (2015)

Prognostic significance of CD8(+) tumor-infiltrating lymphocytes and CD66b(+) tumor-associated neutrophils in the invasive margins of stages I–III colorectal cancer
por: Yin, Chengzeng, et al.
Publicado: (2022)

Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity
por: Ding, Ling, et al.
Publicado: (2021)

A RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer
por: Yamada, Atsushi, et al.
Publicado: (2018)

Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer
por: Toden, Shusuke, et al.
Publicado: (2016)

Pleiotropic effects of DCLK1 in cancer and cancer stem cells
por: Chhetri, Dibyashree, et al.
Publicado: (2022)

The prognostic nutritional index for postoperative infectious complication in patients with ulcerative colitis undergoing proctectomy with ileal pouch-anal anastomosis following subtotal colectomy
por: Okita, Yoshiki, et al.
Publicado: (2019)

Clinical significance and biological role of L1 cell adhesion molecule in gastric cancer
por: Ichikawa, Takashi, et al.
Publicado: (2019)

Neutrophil priming as a risk factor for surgical site infection in patients with colon cancer treated by laparoscopic surgery
por: Toiyama, Yuji, et al.
Publicado: (2020)

The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin
por: Galvan, Laurie, et al.
Publicado: (2018)

DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma
por: Lorenzo, Nevi, et al.
Publicado: (2021)

DCLK1 Inhibition Sensitizes Colorectal Cancer Cells to Radiation Treatment
por: Mohammadi, Chiman, et al.
Publicado: (2021)

Structure-Guided Prediction of the Functional Impact of DCLK1 Mutations on Tumorigenesis
por: Carli, Annalisa L. E., et al.
Publicado: (2023)

In Vivo Time-Course Imaging of Tumor Angiogenesis in Colorectal Liver Metastases in the Same Living Mice Using Two-Photon Laser Scanning Microscopy
por: Tanaka, Koji, et al.
Publicado: (2012)

Molecular characteristics of residual cancer and stromal cells after chemoradiotherapy for gastric cancer: report of four cases
por: Tanaka, Koji, et al.
Publicado: (2014)

Downregulation of trefoil factor-3 expression in the rectum is associated with the development of ulcerative colitis-associated cancer
por: Kondo, Satoru, et al.
Publicado: (2018)

Cumulative C-reactive Protein in the Perioperative Period as a Novel Marker for Oncological Outcome in Patients with Colorectal Cancer Undergoing Curative Resection
por: Fujikawa, Hiroyuki, et al.
Publicado: (2021)

Clinical Relevance of Myopenia and Myosteatosis in Colorectal Cancer
por: Okugawa, Yoshinaga, et al.
Publicado: (2022)

Extraction of a metallic susceptor after accidental ingestion of the heated tobaccostick TEREA™: a case report
por: Higashi, Koki, et al.
Publicado: (2023)

Successful identification of a predictive biomarker for lymph node metastasis in colorectal cancer using a proteomic approach
por: Mori, Koichiro, et al.
Publicado: (2017)

Circulating miR‐203 derived from metastatic tissues promotes myopenia in colorectal cancer patients
por: Okugawa, Yoshinaga, et al.
Publicado: (2019)

Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism
por: Sureban, Sripathi M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lm23md3eb8ilt80f9mdmhr9icq